ADAI has been the home for the Pacific Northwest Node of the National Institute on Drug Abuse’s National Drug Abuse Treatment Clinical Trials Network (CTN) since 2001. The CTN’s goal is to move substance abuse treatments with demonstrated efficacy into community-based treatment settings to determine their effectiveness when implemented in real-world treatment settings.
We have an opening for a Research Scientist who will function as the National Project Director for two HIV prevention studies in the CTN. One has already been funded (PrEP Survey) and is an HIV prevention implementation science survey study designed to identify barriers and facilitators to scaling up Pre-Exposure Phrophylaxis (PrEP) to substance-using men who have sex with men in high-HIV incidence cities in the US. A second study, pending funding, is a medication adherence trial of PrEP in substance-using men who have sex with men and in people who inject drugs. This position will work with Lead Investigators at ADAI, Columbia and Yale Universities, and with other Lead Team members, on the development, implementation, and dissemination of the studies. Secondarily, this position may involve work on other opioid-related clinical treatment trials on an as-needed basis. Examples include a rapid buprenorphine induction trial in emergency departments, and an evaluation of rural hub-and-spoke models to deliver medication assisted treatment to people with opioid use disorders in rural Washington.
For the full description and application instructions, see Req. # 158200 at UW Hires.
